Real-World Data and Real-World Evidence in Lung Cancer Volume II

1,382
Total downloads
11k
Total views and downloads

Articles

CASE REPORT

Published on 13 Oct 2025

Durable clinical benefit from gefitinib plus bevacizumab in a non-small cell lung cancer patient with an acquired C797S mutation following osimertinib treatment: a case report and literature review

Yuping Tan
Meng Dong
Xi Li
Wenbo Li
Fei Xiong
Weidong Bao
Yongzhou Dai
Linjun Yue
Yuan Liu

doi 10.3389/fonc.2025.1673836

499 views

ORIGINAL RESEARCH

Accepted on 08 Oct 2025

Real-World Survival Patterns and Multimodal Therapy Utilization in Small Cell Lung Cancer: A Retrospective Cohort Study in a Chinese Countryside Hospital

Taosheng Huang
Linjie Ma
Mingfang Wang
Xumei Pang
Jiying Xu
Xi Chen
Yutao Xia
Min Yan
Wenxiang Zhao
3 more
Peng Wang

doi 10.3389/fonc.2025.1636533

144 views

CASE REPORT

Accepted on 08 Oct 2025

Analysis of Short-Term Clinical Efficacy of Trilaciclib in Patients with Advanced Lung Neuroendocrine Carcinoma Undergoing Chemotherapy

Yan Zeng
Nan Lin

doi 10.3389/fonc.2025.1685910

142 views

ORIGINAL RESEARCH

Published on 08 Oct 2025

To treat or not to treat? Adjuvant chemotherapy in 46 patients with stage IB lung squamous cell carcinoma: a real-world matched analysis

Botao Liang
Tingting Fu
Juntang Guo
Lianbin Zhang
Chaoyang Liang
Tao Zhang
Kai Zhao
Zhaofeng Gao
Jing Yang
Leilei Shen

doi 10.3389/fonc.2025.1647649

604 views

CASE REPORT

Accepted on 03 Oct 2025

Different therapeutic responses to osimertinib as first-line treatment for cavitated and non-cavitated squamous cell lung cancer with rare EGFR exon 19 deletion: Two case reports and a literature review

Jing Ren
Liang Xiao Cheng
Rui Zhang
Zhi Zou
Zhao Yong Zhou
Xi Zheng

doi 10.3389/fonc.2025.1626665

713 views

ORIGINAL RESEARCH

Accepted on 30 Sep 2025

Durvalumab following definitive chemoradiotherapy among patients with stage III NSCLC in Thai populations: a real-world, multi-center observational study

Piyada Sitthideatphaiboon
Thanyanan Reungwetwattana
Sureerat Jaruhathai
Archara Supavavej
Piyarat Limpawittayakul
Kunlatida Maneenil
Krittiya Korphaisarn
Thatthan Suksombooncharoen
LUANGYOT THONGTHIEANG
4 more
Virote Sriuranpong

doi 10.3389/fonc.2025.1647385

228 views

ORIGINAL RESEARCH

Accepted on 29 Sep 2025

Marked Under-Diagnosis of Lambert-Eaton Myasthenic Syndrome in Small Cell Lung Cancer: An Analysis of Real-World Claims Data

Benjamin Drapkin
David Morrell
Regina Grebla
Guy Shechter
David Gerber

doi 10.3389/fonc.2025.1650373

565 views

ORIGINAL RESEARCH

Published on 26 Sep 2025

Association of the triglyceride-glucose index with immunotherapy efficacy and long-term prognosis in advanced Non-small cell lung cancer

Lijie Ma
Wanling Zhu
Yulang Wang
Li Zhao
Xiangju Wei
Xianmin Xiong
Guijuan Ji

doi 10.3389/fonc.2025.1616302

2,344 views

ORIGINAL RESEARCH

Published on 29 Jul 2025

NGS coverage accurately predicts MET and HER2 (ERBB2) gene amplifications in a real-world non-small cell lung cancer cohort

Adam Kowalewski
Janna Siemanowski-Hrach
Thomas Stehle
Jan Rehker
Udo Siebolts
Sabine Merkelbach-Bruse
Carina Heydt

doi 10.3389/fonc.2025.1618509

1,134 views

ORIGINAL RESEARCH

Published on 30 May 2025

Cost-effectiveness analysis of first-line tislelizumab plus chemotherapy for extensive-stage small cell lung cancer from the perspective of the healthcare system in China

Feng Chen
Xue Feng
Lin Lin Xiao
Hai Juan Tang
Shu Xia Qin
Jie Ping Peng
Jing Bai

doi 10.3389/fpubh.2025.1552734

1,541 views

ORIGINAL RESEARCH

Published on 01 May 2025

Real-world analysis of the efficacy and safety of lorlatinib in ALK-positive non-small cell lung cancer patients in China

Guangming Tian
Jun Nie
Ling Dai
Weiheng Hu
Jie Zhang
Di Wu
Xiangjuan Ma
Xiaoling Chen
Sen Han
4 more
Jian Fang

doi 10.3389/fonc.2025.1577607

2,210 views

Share on

Frontiers in Oncology

Thoracic Oncology

Participating Journals

Frontiers in Public Health
- Health Economics
- 3.4 impact factor
- 5.5 citescore

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

11kTopic views
9,853Article views
1,382Article downloads

View impact

Articles

Durable clinical benefit from gefitinib plus bevacizumab in a non-small cell lung cancer patient with an acquired C797S mutation following osimertinib treatment: a case report and literature review

Real-World Survival Patterns and Multimodal Therapy Utilization in Small Cell Lung Cancer: A Retrospective Cohort Study in a Chinese Countryside Hospital

Analysis of Short-Term Clinical Efficacy of Trilaciclib in Patients with Advanced Lung Neuroendocrine Carcinoma Undergoing Chemotherapy

To treat or not to treat? Adjuvant chemotherapy in 46 patients with stage IB lung squamous cell carcinoma: a real-world matched analysis

Different therapeutic responses to osimertinib as first-line treatment for cavitated and non-cavitated squamous cell lung cancer with rare EGFR exon 19 deletion: Two case reports and a literature review

Durvalumab following definitive chemoradiotherapy among patients with stage III NSCLC in Thai populations: a real-world, multi-center observational study

Marked Under-Diagnosis of Lambert-Eaton Myasthenic Syndrome in Small Cell Lung Cancer: An Analysis of Real-World Claims Data

Association of the triglyceride-glucose index with immunotherapy efficacy and long-term prognosis in advanced Non-small cell lung cancer

NGS coverage accurately predicts MET and HER2 (ERBB2) gene amplifications in a real-world non-small cell lung cancer cohort

Cost-effectiveness analysis of first-line tislelizumab plus chemotherapy for extensive-stage small cell lung cancer from the perspective of the healthcare system in China

Real-world analysis of the efficacy and safety of lorlatinib in ALK-positive non-small cell lung cancer patients in China

Frontiers in Oncology

Thoracic Oncology

Participating Journals

Frontiers in Public Health

Health Economics